Table 2.
Relative risk |
|||
---|---|---|---|
Risk factor | Hazard ratio | 95% Confidence interval | P |
Sex | |||
Men vs women ≤ 13 y | 2.31 | 1.41–3.92 | .003 |
Men vs women >13 y | 0.92 | 0.61–1.51 | .72 |
Mutation location (vs nonmissense mutations) | |||
Cytoplasmic loop (S2–S3/S4–S5 linkers) | 1.93 | 1.37–2.75 | .005 |
MS (S1, S2, S3, S4, S5, P-loop, S6) | 1.02 | 0.71–1.85 | .51 |
N/C terminus | 0.96 | 0.52–1.57 | .72 |
QTc duration (ms) | |||
>550 vs <500 | 4.18 | 2.06–8.46 | <.001 |
500–550 vs <500 | 3.35 | 1.83–6.11 | <.001 |
Time-dependent syncope | |||
Syncope vs no syncope | 3.40 | 2.22–5.21 | <.001 |
ACA = aborted cardiac arrest; LQT1 = long QT syndrome type 1; MS = membrane spanning; QTc = corrected QT interval; SCD = sudden cardiac death.
Models were further adjusted for missing QTc values, time-dependent beta-blocker therapy.